AMPH Stock Price Chart More Charts

AMPH Price/Volume Stats

Amphastar Pharmaceuticals, Inc. (AMPH) Company Bio

Amphastar Pharmaceuticals focuses on the development, manufacture, marketing, and sale of generic and proprietary injectable and inhalation products. It operates in two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredients. The company was founded in 1996 and is based in Rancho Cucamonga, California.

AMPH Price Forecast Based on DCF Valuation

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Amphastar Pharmaceuticals Inc. To summarize, we found that Amphastar Pharmaceuticals Inc ranked in the 17st percentile in terms of potential gain offered. The most interesting components of our discounted cash flow analysis for Amphastar Pharmaceuticals Inc ended up being:

• As a business, AMPH is generating more cash flow than just 13.17% of positive cash flow stocks in the Healthcare.
• The business' balance sheet reveals debt to be 6% of the company's capital (with equity being the remaining amount). Approximately only 19.06% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
• AMPH's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 50.17% of tickers in our DCF set.

PKI, CRY, SNN, ZBH, and DXCM can be thought of as valuation peers to AMPH, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.